New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 5, 2013
12:40 EDTBOTABiota Pharmaceuticals Chief Accounting Officer terminated
Biota Pharmaceuticals disclosed in a regulatory filing that it terminated Ron Kocak, the company’s former corporate controller and Chief Accounting Officer, effective July 1. The duties and responsibilities of the principal accounting officer will be assumed by Peter Azzarello, the company’s VP of finance.
News For BOTA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 20, 2015
09:28 EDTBOTABiota Pharmaceuticals commences dosing of BTA585 Phase 1 trial
Biota Pharmaceuticals announced that it has commenced dosing in a 50-subject, randomized, placebo-controlled, Phase 1 single ascending dose, or SAD, trial to evaluate the safety and pharmacokinetics, or PK, of BTA585 in healthy volunteers. BTA585, a potent inhibitor of viral entry into cells, is an orally bioavailable compound in clinical development for the treatment of respiratory syncytial virus, RSV, infections in children, the elderly and immunocompromised patients.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use